Company Filing History:
Years Active: 2021
Title: Jichen Zhao: Innovator in Alkyl Pyrrolopyrimidine Compounds
Introduction
Jichen Zhao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific tyrosine kinases. His work has implications for treating various medical conditions, including cancer.
Latest Patents
Jichen Zhao holds a patent for "Alkyl pyrrolopyrimidine analogs and methods of making and using same." This patent focuses on benzo annulene compounds that can inhibit Mer tyrosine kinase and/or Tyro3 tyrosine kinase. The methods described in the patent are aimed at treating bacterial infections, viral infections, and disorders of uncontrolled cellular proliferation, such as cancer. The abstract serves as a scanning tool for searching in the relevant field and is not intended to limit the scope of the invention.
Career Highlights
Throughout his career, Jichen Zhao has worked with prestigious institutions, including the University of North Carolina at Chapel Hill and Novartis AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Jichen Zhao's notable coworkers include Xiaodong Wang and Hongchao Zheng. Their collaborative efforts have further advanced the research and development of innovative compounds.
Conclusion
Jichen Zhao's work in the field of alkyl pyrrolopyrimidine compounds showcases his dedication to advancing medical science. His patent and collaborations highlight the importance of innovation in addressing critical health challenges.